Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands
- PMID: 2479025
- PMCID: PMC298324
- DOI: 10.1073/pnas.86.21.8570
Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands
Abstract
The regional and cellular localization of the two subtypes of dopamine receptors, D1 and D2, have been ascertained in rat forebrain by use of fluorescent dopaminergic antagonist ligands. (R,S)-5-(4'-aminophenyl)-8-chloro-2,3,4,5-tetrahydro-3- methyl-[1H]-3-benzazepin-7-ol, the 4'-amino derivative of the high-affinity D1-specific antagonist SCH 23390, and the D2 selective antagonist N-(p-aminophenethyl)spiperone were chemically derivatized using the fluorescent compound tetramethylrhodamine. The modification of these antagonist ligands has allowed the specific, cellular resolution of the D1 and D2 receptor binding sites in intact, highly organized regions of forebrain slices in a very rapid experimental time frame. The regional localization of receptors labeled by the fluorescent probes is in agreement with previous receptor autoradiography studies. Moreover, the specific cellular binding patterns for both receptors can now be compared and contrasted to one another in the same tissue by using these fluorescent ligands. D1 receptor sites are most evident within the striatum and exhibit regions of intense "patch" fluorescence corresponding to receptor reactivity in cells and their processes. The distribution of D1 receptor binding is highly analogous to the pattern of dopamine terminal histofluorescence in the caudate nucleus. D2 receptor sites are less prevalent overall and may be localized to a subpopulation of the D1 fluorescent neurons in the caudate nucleus and nucleus accumbens regions.
Similar articles
-
Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues.Brain Res. 1991 May 3;547(2):208-22. doi: 10.1016/0006-8993(91)90964-w. Brain Res. 1991. PMID: 1884196
-
Characterization of novel fluorescent ligands with high affinity for D1 and D2 dopaminergic receptors.J Neurochem. 1989 May;52(5):1641-4. doi: 10.1111/j.1471-4159.1989.tb09220.x. J Neurochem. 1989. PMID: 2523470
-
Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity.Brain Res. 1991 May 3;547(2):199-207. doi: 10.1016/0006-8993(91)90963-v. Brain Res. 1991. PMID: 1679366
-
(R)-(+)-8-Chloro-2,3,4,5-tetrahydro-3-[11C]methyl-5-phenyl-1H-3-benzazepin-7-ol ([11C]SCH 23390).2005 Nov 22 [updated 2012 Jan 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2005 Nov 22 [updated 2012 Jan 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641454 Free Books & Documents. Review.
-
(+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-[11C]methyl-2,3,4,5-tetrahydro-1H-3-benzazepine.2006 Mar 17 [updated 2008 Jan 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 Mar 17 [updated 2008 Jan 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641216 Free Books & Documents. Review.
Cited by
-
G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.Front Neuroendocrinol. 2012 Jan;33(1):45-66. doi: 10.1016/j.yfrne.2011.07.002. Epub 2011 Jul 23. Front Neuroendocrinol. 2012. PMID: 21802439 Free PMC article. Review.
-
Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson's Disease Drugs.ACS Chem Neurosci. 2022 Oct 19;13(20):3008-3022. doi: 10.1021/acschemneuro.2c00544. Epub 2022 Oct 2. ACS Chem Neurosci. 2022. PMID: 36183275 Free PMC article.
-
Cell imaging of dopamine receptor using agonist labeling iridium(iii) complex.Chem Sci. 2017 Dec 19;9(5):1119-1125. doi: 10.1039/c7sc04798c. eCollection 2018 Feb 7. Chem Sci. 2017. PMID: 29675156 Free PMC article.
-
Characterization of anti-peptide antibodies for the localization of D2 dopamine receptors in rat striatum.Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1441-5. doi: 10.1073/pnas.88.4.1441. Proc Natl Acad Sci U S A. 1991. PMID: 1825357 Free PMC article.
-
Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders.CNS Neurosci Ther. 2010 Jun;16(3):e92-123. doi: 10.1111/j.1755-5949.2010.00154.x. CNS Neurosci Ther. 2010. PMID: 20557568 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous